Jason Hsu bought $267k of IMMX
director at Immix Biopharma, Inc.. 56,000 shares at an average of $4.77, traded Dec 8, 2023, filed Dec 12, 2023.
Score components
- +15RoleDirector
- +13Trade size$267k at market
- +3Relative to holdingsHoldings up 7%
- 0Price contextNear the top of the 52-week range
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-23-044618, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 8, 2023 | POpen-market purchase Common Stock | +25,000 | $4.88 | $122k | 782,000 | Dec 12, 2023 |
| Dec 11, 2023 | POpen-market purchase Common Stock | +31,000 | $4.67 | $145k | 813,000 | Dec 12, 2023 |
Related signals
Other insiders at Immix Biopharma, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | Immix Biopharma, Inc. | Gabriel S Morris CFO | $5,067 770 shares | +0% | |
| 33Weak | Immix Biopharma, Inc. | Ilya M Rachman CEO and Chairman | $4,976 746 shares | +0% | |
| 38Weak | Immix Biopharma, Inc. | Gabriel S Morris CFO | $5,122 2,600 shares | +1% | |
| 36Weak | Immix Biopharma, Inc. | Ilya M Rachman CEO and Chairman | $5,050 2,500 shares | +0% | |
| 25Weak | Immix Biopharma, Inc. | Gabriel S Morris CFO | $5,071 2,225 shares | +1% | |
| 28Weak | Immix Biopharma, Inc. | Ilya M Rachman CEO and Chairman | $4,999 2,178 shares | +0% | |
| 28Weak | IMMXbuy Immix Biopharma, Inc. | Jason Hsu director | $104k 47,700 shares | +6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.